Please Wait.....
Report
Acute Pancreatitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP), Other treatments), By Diagnosis (Imaging tests, Laboratory Tests), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others) By Region & Competition, 2020-2030F
Market Report I 2025-03-28 I 185 Pages I TechSci Research
Global Acute Pancreatitis Market was valued at USD 5.10 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.59% through 2030. The Global Acute Pancreatitis Market is a dynamic and evolving sector within the healthcare industry that encompasses the diagnosis, treatment, and management of acute pancreatitis, a severe inflammatory condition of the pancreas. This market has witnessed significant growth and transformation in recent years due to various factors, including changing lifestyle patterns, increasing alcohol consumption, and a rising incidence of obesity, all of which are contributing to the growing prevalence of acute pancreatitis worldwide. According to a November 2022 article by the NLM, acute pancreatitis is the most common gastrointestinal condition and the leading cause of hospitalization in the United States. Additionally, a July 2022 MedRxiv article reported that gallstone disease accounted for approximately 2.2 million ambulatory care visits, 1.1 million emergency department visits, and 615,000 hospital discharges. The same source noted that women are more likely to develop gallstones than men. One of the key drivers of this market is the increasing awareness and early diagnosis of acute pancreatitis, which has led to a surge in demand for diagnostic tests, such as imaging studies and blood tests, to accurately identify and assess the severity of the condition.
Key Market Drivers
Changing Lifestyle Patterns and Risk Factors
The global acute pancreatitis market is experiencing significant growth, in large part due to changing lifestyle patterns and the associated risk factors that are driving the increasing prevalence of this painful and potentially life-threatening condition. Modern lifestyles characterized by unhealthy dietary habits, high alcohol consumption, and a rising global obesity epidemic have created a perfect storm of risk factors that are contributing to the surge in acute pancreatitis cases worldwide. For instance, in December 2022, St. Jude Children's Research Hospital, in partnership with CalciMedica, Inc., initiated a Phase I/II clinical trial to evaluate the safety and effectiveness of CM4620 in children and young adults with asparaginase-induced acute pancreatitis. Also, in October 2022, Regeneron Pharmaceuticals initiated a Phase II clinical trial to assess the efficacy and safety of evinacumab in patients with severe hypertriglyceridemia to prevent recurrent acute pancreatitis.
Key Market Challenges
High Treatment Costs
One of the primary drivers of high treatment costs for acute pancreatitis is the need for hospitalization. Severe cases of acute pancreatitis often require extended stays in the hospital, where patients receive specialized care, including pain management, nutritional support, and monitoring for complications. These extended hospital stays can result in exorbitant medical bills, particularly in countries with private healthcare systems. Early and accurate diagnosis of acute pancreatitis is critical for effective management. However, diagnostic tests, such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and blood work, can be expensive. The cost of these diagnostic procedures can escalate the overall financial burden on patients and healthcare systems. In cases of severe acute pancreatitis, surgical interventions may be necessary to address complications like infected pancreatic necrosis or pseudocysts. Surgery, especially when performed laparoscopically or using minimally invasive techniques, can be costly and contribute significantly to the overall treatment expenses.
Key Market Trends
Advancements in Minimally Invasive Surgery
Advancements in minimally invasive surgical techniques have emerged as a pivotal trend in the global acute pancreatitis market, revolutionizing the treatment landscape for this severe pancreatic condition. Minimally invasive surgery (MIS), which includes procedures like laparoscopy and endoscopy, offers significant benefits such as reduced postoperative pain, shorter hospital stays, and faster patient recovery times. These advantages have not only improved patient outcomes but also contributed to the growth of the acute pancreatitis market in several ways.
One of the primary ways in which MIS is boosting the market is by enhancing patient comfort and overall satisfaction. Traditional open surgeries for acute pancreatitis often involve larger incisions and more extensive tissue disruption, leading to prolonged postoperative pain and recovery periods. In contrast, minimally invasive approaches involve smaller incisions, resulting in less pain, reduced scarring, and shorter hospitalization. This patient-centric focus has made MIS an attractive option for both patients and healthcare providers, driving its adoption and contributing to market growth.
Key Market Players
- SCM Lifescience
- GNT Pharma Co
- Baxter International Inc.
- B. Braun Melsungen AG
- General Electric Company
- Medtronic Plc
- Boston Scientific Corporation
- Fresenius Kabi USA
- McNeil Consumer Healthcare
- Sun BioPharma
Report Scope:
In this report, the Global Acute Pancreatitis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Acute Pancreatitis Market, By Treatment:
o Intravenous Fluid
o Nutritional Support
o Analgesics
o Endoscopic Retrograde Cholangiopancreatography (ERCP)
o Other treatments
- Acute Pancreatitis Market, By Diagnosis:
o Imaging tests
o Laboratory Tests
- Acute Pancreatitis Market, By End-User:
o Hospitals & Clinics
o Ambulatory care Centers
o Others
- Acute Pancreatitis Market, By Region:
o North America
United States
Canada
Mexico
o Europe
France
United Kingdom
Italy
Germany
Spain
o Asia-Pacific
China
India
Japan
Australia
South Korea
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Acute Pancreatitis Market.
Available Customizations:
Global Acute Pancreatitis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Acute Pancreatitis Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Treatment (Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP), Other treatments)
4.2.2. By Diagnosis (Imaging tests, Laboratory Tests)
4.2.3. By End-User (Hospitals & Clinics, Ambulatory care Centers, Others)
4.2.4. By Region
4.2.5. By Company (2024)
4.3. Market Map
4.3.1. By Treatment
4.3.2. By Diagnosis
4.3.3. By End-User
4.3.4. By Region
5. Asia Pacific Acute Pancreatitis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Treatment
5.2.2. By Diagnosis
5.2.3. By End-User
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Acute Pancreatitis Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Treatment
5.3.1.2.2. By Diagnosis
5.3.1.2.3. By End-User
5.3.2. India Acute Pancreatitis Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Treatment
5.3.2.2.2. By Diagnosis
5.3.2.2.3. By End-User
5.3.3. Australia Acute Pancreatitis Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Treatment
5.3.3.2.2. By Diagnosis
5.3.3.2.3. By End-User
5.3.4. Japan Acute Pancreatitis Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Treatment
5.3.4.2.2. By Diagnosis
5.3.4.2.3. By End-User
5.3.5. South Korea Acute Pancreatitis Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Treatment
5.3.5.2.2. By Diagnosis
5.3.5.2.3. By End-User
6. Europe Acute Pancreatitis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Treatment
6.2.2. By Diagnosis
6.2.3. By End-User
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Acute Pancreatitis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Treatment
6.3.1.2.2. By Diagnosis
6.3.1.2.3. By End-User
6.3.2. Germany Acute Pancreatitis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Treatment
6.3.2.2.2. By Diagnosis
6.3.2.2.3. By End-User
6.3.3. Spain Acute Pancreatitis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Treatment
6.3.3.2.2. By Diagnosis
6.3.3.2.3. By End-User
6.3.4. Italy Acute Pancreatitis Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Treatment
6.3.4.2.2. By Diagnosis
6.3.4.2.3. By End-User
6.3.5. United Kingdom Acute Pancreatitis Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Treatment
6.3.5.2.2. By Diagnosis
6.3.5.2.3. By End-User
7. North America Acute Pancreatitis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Treatment
7.2.2. By Diagnosis
7.2.3. By End-User
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Acute Pancreatitis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Treatment
7.3.1.2.2. By Diagnosis
7.3.1.2.3. By End-User
7.3.2. Mexico Acute Pancreatitis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Treatment
7.3.2.2.2. By Diagnosis
7.3.2.2.3. By End-User
7.3.3. Canada Acute Pancreatitis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Treatment
7.3.3.2.2. By Diagnosis
7.3.3.2.3. By End-User
8. South America Acute Pancreatitis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Treatment
8.2.2. By Diagnosis
8.2.3. By End-User
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Acute Pancreatitis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Treatment
8.3.1.2.2. By Diagnosis
8.3.1.2.3. By End-User
8.3.2. Argentina Acute Pancreatitis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Treatment
8.3.2.2.2. By Diagnosis
8.3.2.2.3. By End-User
8.3.3. Colombia Acute Pancreatitis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Treatment
8.3.3.2.2. By Diagnosis
8.3.3.2.3. By End-User
9. Middle East and Africa Acute Pancreatitis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Treatment
9.2.2. By Diagnosis
9.2.3. By End-User
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Acute Pancreatitis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Treatment
9.3.1.2.2. By Diagnosis
9.3.1.2.3. By End-User
9.3.2. Saudi Arabia Acute Pancreatitis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Treatment
9.3.2.2.2. By Diagnosis
9.3.2.2.3. By End-User
9.3.3. UAE Acute Pancreatitis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Treatment
9.3.3.2.2. By Diagnosis
9.3.3.2.3. By End-User
9.3.4. Egypt Acute Pancreatitis Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Treatment
9.3.4.2.2. By Diagnosis
9.3.4.2.3. By End-User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Global Acute Pancreatitis Market: SWOT Analysis
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. Competitive Landscape
14.1. SCM Lifescience
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Current Capacity Analysis
14.1.5. Financials (In case of listed)
14.1.6. Recent Developments
14.1.7. SWOT Analysis
14.2. GNT Pharma Co
14.3. Baxter International Inc.
14.4. B. Braun Melsungen AG
14.5. General Electric Company
14.6. Medtronic Plc
14.7. Boston Scientific Corporation
14.8. Fresenius Kabi USA
14.9. McNeil Consumer Healthcare
14.10. Sun BioPharma
15. Strategic Recommendations
16. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security